# DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer

> **NCT00024401** · PHASE2 · UNKNOWN · sponsor: **Theradex**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** DHA-paclitaxel

## Key facts

- **NCT ID:** NCT00024401
- **Lead sponsor:** Theradex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00024401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00024401, "DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00024401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*